<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="782" width="593">
	<fontspec id="font0" size="9" family="AdvC2866" color="#231f20"/>
	<fontspec id="font1" size="6" family="AdvC2866" color="#231f20"/>
	<fontspec id="font2" size="9" family="AdvPSMP13" color="#231f20"/>
	<fontspec id="font3" size="8" family="AdvPSMy-R" color="#231f20"/>
<text top="50" left="45" width="243" height="8" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="text">ted that EL mass concentrations in pre-heparin plasma were</text>
<text top="61" left="45" width="243" height="8" font="font0" id="p1_t2" reading_order_no="2" segment_no="1" tag_type="text">higher than those of LPL [34–37], and injection of heparin</text>
<text top="72" left="45" width="243" height="8" font="font0" id="p1_t3" reading_order_no="3" segment_no="1" tag_type="text">resulted in a 3-fold increase in plasma EL mass to concen-</text>
<text top="83" left="45" width="243" height="8" font="font0" id="p1_t4" reading_order_no="4" segment_no="1" tag_type="text">trations similar to those reported for HL [34,38]. Importantly,</text>
<text top="93" left="45" width="243" height="8" font="font0" id="p1_t5" reading_order_no="5" segment_no="1" tag_type="text">within individuals, the pre-heparin and post-heparin EL</text>
<text top="104" left="45" width="243" height="8" font="font0" id="p1_t6" reading_order_no="6" segment_no="1" tag_type="text">concentrations are signiﬁcantly correlated, suggesting that</text>
<text top="115" left="45" width="243" height="8" font="font0" id="p1_t7" reading_order_no="7" segment_no="1" tag_type="text">pre-heparin EL mass may be a surrogate marker for total</text>
<text top="126" left="45" width="243" height="8" font="font0" id="p1_t8" reading_order_no="8" segment_no="1" tag_type="text">vascular EL expression. Indeed, most of the associations</text>
<text top="137" left="45" width="243" height="8" font="font0" id="p1_t9" reading_order_no="9" segment_no="1" tag_type="text">between post-heparin EL mass and metabolic syndrome</text>
<text top="148" left="45" width="243" height="8" font="font0" id="p1_t10" reading_order_no="10" segment_no="1" tag_type="text">factors, cardiovascular risk factors, lipids, and CAC were also</text>
<text top="159" left="45" width="243" height="8" font="font0" id="p1_t11" reading_order_no="11" segment_no="1" tag_type="text">found for pre-heparin concentrations. This suggests that</text>
<text top="170" left="45" width="243" height="8" font="font0" id="p1_t12" reading_order_no="12" segment_no="1" tag_type="text">future studies of the association of EL mass concentrations</text>
<text top="181" left="45" width="243" height="8" font="font0" id="p1_t13" reading_order_no="13" segment_no="1" tag_type="text">with cardiovascular outcomes may be able to be performed</text>
<text top="192" left="45" width="173" height="8" font="font0" id="p1_t14" reading_order_no="14" segment_no="1" tag_type="text">using routine, pre-heparin plasma samples.</text>
<text top="203" left="54" width="234" height="8" font="font0" id="p1_t15" reading_order_no="15" segment_no="3" tag_type="text">We previously reported that overexpression of EL in</text>
<text top="214" left="45" width="243" height="8" font="font0" id="p1_t16" reading_order_no="16" segment_no="3" tag_type="text">hyperlipidemic mouse models reduced concentrations of</text>
<text top="225" left="45" width="243" height="8" font="font0" id="p1_t17" reading_order_no="17" segment_no="3" tag_type="text">apoB-containing lipoproteins [39]. However, in this human</text>
<text top="236" left="45" width="243" height="8" font="font0" id="p1_t18" reading_order_no="18" segment_no="3" tag_type="text">study, we found that concentrations of EL are positively</text>
<text top="247" left="45" width="243" height="8" font="font0" id="p1_t19" reading_order_no="19" segment_no="3" tag_type="text">associated with plasma concentrations of LDL-C, triglycer-</text>
<text top="258" left="45" width="243" height="8" font="font0" id="p1_t20" reading_order_no="20" segment_no="3" tag_type="text">ides, and apoB, but did not correlate with the number of</text>
<text top="269" left="45" width="243" height="8" font="font0" id="p1_t21" reading_order_no="21" segment_no="3" tag_type="text">particles in LDL subfractions. This is in contrast to HL, which</text>
<text top="280" left="45" width="243" height="8" font="font0" id="p1_t22" reading_order_no="22" segment_no="3" tag_type="text">hydrolyzes remnant lipoproteins and is negatively associated</text>
<text top="291" left="45" width="243" height="8" font="font0" id="p1_t23" reading_order_no="23" segment_no="3" tag_type="text">with remnant particles and positively associated with con-</text>
<text top="302" left="45" width="243" height="8" font="font0" id="p1_t24" reading_order_no="24" segment_no="3" tag_type="text">centrations of small, dense LDL particles [40]. The positive</text>
<text top="313" left="45" width="243" height="8" font="font0" id="p1_t25" reading_order_no="25" segment_no="3" tag_type="text">association of EL with apoB-containing lipoproteins is most</text>
<text top="324" left="45" width="243" height="8" font="font0" id="p1_t26" reading_order_no="26" segment_no="3" tag_type="text">likely the reﬂection of the concomitant increase in VLDL and</text>
<text top="335" left="45" width="243" height="8" font="font0" id="p1_t27" reading_order_no="27" segment_no="3" tag_type="text">triglycerides [41] and EL mass found in obese individuals and</text>
<text top="346" left="45" width="127" height="8" font="font0" id="p1_t28" reading_order_no="28" segment_no="3" tag_type="text">those with metabolic syndrome.</text>
<text top="357" left="54" width="234" height="8" font="font0" id="p1_t29" reading_order_no="29" segment_no="6" tag_type="text">This is the ﬁrst study to demonstrate that, in humans, EL</text>
<text top="368" left="45" width="243" height="8" font="font0" id="p1_t30" reading_order_no="30" segment_no="6" tag_type="text">plasma concentrations are negatively associated with HDL-C</text>
<text top="379" left="45" width="243" height="8" font="font0" id="p1_t31" reading_order_no="31" segment_no="6" tag_type="text">concentrations. While the negative correlations found be-</text>
<text top="390" left="45" width="243" height="8" font="font0" id="p1_t32" reading_order_no="32" segment_no="6" tag_type="text">tween plasma EL mass concentrations and HDL-C concen-</text>
<text top="401" left="45" width="243" height="8" font="font0" id="p1_t33" reading_order_no="33" segment_no="6" tag_type="text">trations are decidedly modest, they are highly statistically</text>
<text top="411" left="45" width="243" height="8" font="font0" id="p1_t34" reading_order_no="34" segment_no="6" tag_type="text">signiﬁcant. The correlation between plasma EL mass and</text>
<text top="422" left="45" width="243" height="8" font="font0" id="p1_t35" reading_order_no="35" segment_no="6" tag_type="text">HDL-C may, in fact, underestimate the association of EL</text>
<text top="433" left="45" width="243" height="8" font="font0" id="p1_t36" reading_order_no="36" segment_no="6" tag_type="text">activity with HDL-C, given that the EL mass assay may only</text>
<text top="444" left="45" width="243" height="8" font="font0" id="p1_t37" reading_order_no="37" segment_no="6" tag_type="text">partially reﬂect the biological activity of EL. This ﬁnding is</text>
<text top="455" left="45" width="243" height="8" font="font0" id="p1_t38" reading_order_no="38" segment_no="6" tag_type="text">consistent with published reports in mice that overexpression</text>
<text top="466" left="45" width="243" height="8" font="font0" id="p1_t39" reading_order_no="39" segment_no="6" tag_type="text">of EL dramatically reduces HDL-C concentrations [6,9], and</text>
<text top="477" left="45" width="243" height="8" font="font0" id="p1_t40" reading_order_no="40" segment_no="6" tag_type="text">either inhibition of EL or genetic deletion causes an increase</text>
<text top="488" left="45" width="243" height="8" font="font0" id="p1_t41" reading_order_no="41" segment_no="6" tag_type="text">in HDL-C [9,10,11]. Furthermore, we show that EL concen-</text>
<text top="499" left="45" width="243" height="8" font="font0" id="p1_t42" reading_order_no="42" segment_no="6" tag_type="text">trations are negatively associated with large HDL but</text>
<text top="510" left="45" width="243" height="8" font="font0" id="p1_t43" reading_order_no="43" segment_no="6" tag_type="text">positively associated with small HDL, consistent with the</text>
<text top="521" left="45" width="243" height="8" font="font0" id="p1_t44" reading_order_no="44" segment_no="6" tag_type="text">model proven in mice [8], whereby EL hydrolyzes surface</text>
<text top="532" left="45" width="243" height="8" font="font0" id="p1_t45" reading_order_no="45" segment_no="6" tag_type="text">phospholipids on large HDL, creating smaller, phospholipid-</text>
<text top="543" left="45" width="243" height="8" font="font0" id="p1_t46" reading_order_no="46" segment_no="6" tag_type="text">depleted HDL particles. This pattern of negative correlation</text>
<text top="554" left="45" width="243" height="8" font="font0" id="p1_t47" reading_order_no="47" segment_no="6" tag_type="text">with large HDL and positive correlation with small HDL has</text>
<text top="565" left="45" width="243" height="8" font="font0" id="p1_t48" reading_order_no="48" segment_no="6" tag_type="text">also been reported for HL [42]. Of signiﬁcance was the lack of</text>
<text top="576" left="45" width="243" height="8" font="font0" id="p1_t49" reading_order_no="49" segment_no="6" tag_type="text">correlation between EL mass concentrations and apoA-I. This</text>
<text top="587" left="45" width="243" height="8" font="font0" id="p1_t50" reading_order_no="50" segment_no="6" tag_type="text">ﬁnding is consistent with the report by Jahangiri [43] that EL</text>
<text top="598" left="45" width="243" height="8" font="font0" id="p1_t51" reading_order_no="51" segment_no="6" tag_type="text">remodeling of HDL to smaller particles does not mediate</text>
<text top="609" left="45" width="80" height="8" font="font0" id="p1_t52" reading_order_no="52" segment_no="6" tag_type="text">apoA-I dissociation.</text>
<text top="620" left="54" width="234" height="8" font="font0" id="p1_t53" reading_order_no="53" segment_no="9" tag_type="text">The apolipoprotein content of HDL has been shown to</text>
<text top="631" left="45" width="243" height="8" font="font0" id="p1_t54" reading_order_no="54" segment_no="9" tag_type="text">inﬂuence the activity of HL and EL toward HDL. Several</text>
<text top="642" left="45" width="243" height="8" font="font0" id="p1_t55" reading_order_no="55" segment_no="9" tag_type="text">reports by Patsch et al. [44] and Mowri et al. [45] have</text>
<text top="653" left="45" width="243" height="8" font="font0" id="p1_t56" reading_order_no="56" segment_no="9" tag_type="text">suggested that an increase in the apoA-II content increases</text>
<text top="664" left="45" width="243" height="9" font="font0" id="p1_t57" reading_order_no="57" segment_no="9" tag_type="text">HL hydrolysis of the triglyceride in the larger HDL 2 particle.</text>
<text top="675" left="45" width="243" height="8" font="font0" id="p1_t58" reading_order_no="58" segment_no="9" tag_type="text">Recent studies by Hedrick et al. [46], using apoA-II transgenic</text>
<text top="686" left="45" width="243" height="8" font="font0" id="p1_t59" reading_order_no="59" segment_no="9" tag_type="text">mice, suggest that apoA-II inhibits HL activity, but the</text>
<text top="697" left="45" width="243" height="8" font="font0" id="p1_t60" reading_order_no="60" segment_no="9" tag_type="text">addition of apoA-I partially reverses this inhibition. Boucher</text>
<text top="708" left="45" width="243" height="8" font="font0" id="p1_t61" reading_order_no="61" segment_no="9" tag_type="text">et al. [47] found similar results in in vitro studies, in which the</text>
<text top="719" left="45" width="243" height="8" font="font0" id="p1_t62" reading_order_no="62" segment_no="9" tag_type="text">addition of apoA-II to apoA-I–containing HDL inhibited</text>
<text top="50" left="306" width="243" height="8" font="font0" id="p1_t63" reading_order_no="63" segment_no="2" tag_type="text">substrate hydrolysis by increasing the afﬁnity of HL for the</text>
<text top="61" left="306" width="243" height="8" font="font0" id="p1_t64" reading_order_no="64" segment_no="2" tag_type="text">HDL particle. The authors reported that the addition of</text>
<text top="72" left="306" width="243" height="8" font="font0" id="p1_t65" reading_order_no="65" segment_no="2" tag_type="text">apoA-II to particles increased HDL size and induced a</text>
<text top="83" left="306" width="243" height="8" font="font0" id="p1_t66" reading_order_no="66" segment_no="2" tag_type="text">conformational change in apoA-I. In contrast, Caiazza et al.</text>
<text top="94" left="306" width="243" height="8" font="font0" id="p1_t67" reading_order_no="67" segment_no="2" tag_type="text">[48] used spherical HDL of identical size, containing</text>
<text top="105" left="306" width="243" height="8" font="font0" id="p1_t68" reading_order_no="68" segment_no="2" tag_type="text">cholesteryl ester as the sole lipid core with phosphatidylcho-</text>
<text top="117" left="306" width="243" height="8" font="font0" id="p1_t69" reading_order_no="69" segment_no="2" tag_type="text">line and apoA-I, apoA-II, or both to determine the inﬂuence</text>
<text top="128" left="306" width="243" height="8" font="font0" id="p1_t70" reading_order_no="70" segment_no="2" tag_type="text">of apolipoproteins on EL activity. They found that EL</text>
<text top="139" left="306" width="243" height="8" font="font0" id="p1_t71" reading_order_no="71" segment_no="2" tag_type="text">hydrolysis of phospholipids in apoA-II–containing HDL was</text>
<text top="150" left="306" width="243" height="8" font="font0" id="p1_t72" reading_order_no="72" segment_no="2" tag_type="text">negligible, measurable in apoA-I–containing HDL, and great-</text>
<text top="161" left="306" width="243" height="8" font="font0" id="p1_t73" reading_order_no="73" segment_no="2" tag_type="text">est in spherical HDL containing both apoA-I and apoA-II.</text>
<text top="172" left="306" width="243" height="8" font="font0" id="p1_t74" reading_order_no="74" segment_no="2" tag_type="text">While the absence of triglycerides in these spherical particles</text>
<text top="183" left="306" width="243" height="8" font="font0" id="p1_t75" reading_order_no="75" segment_no="2" tag_type="text">makes application to native HDL difﬁcult, it does suggest that</text>
<text top="195" left="306" width="243" height="8" font="font0" id="p1_t76" reading_order_no="76" segment_no="2" tag_type="text">there are differences in the subpopulations of HDL to which</text>
<text top="206" left="306" width="68" height="8" font="font0" id="p1_t77" reading_order_no="77" segment_no="2" tag_type="text">HL and EL bind.</text>
<text top="217" left="315" width="234" height="8" font="font0" id="p1_t78" reading_order_no="78" segment_no="4" tag_type="text">Both Jin et al. [49] and Hirata et al. [50] reported that</text>
<text top="228" left="306" width="243" height="8" font="font0" id="p1_t79" reading_order_no="79" segment_no="4" tag_type="text">stimulation of cultured endothelial cells with tumor necrosis</text>
<text top="239" left="306" width="243" height="8" font="font0" id="p1_t80" reading_order_no="80" segment_no="4" tag_type="text">factor- a and interleukin 1 b caused an increase in EL mRNA</text>
<text top="250" left="306" width="243" height="8" font="font0" id="p1_t81" reading_order_no="81" segment_no="4" tag_type="text">expression and protein secretion. Elevated plasma concen-</text>
<text top="261" left="306" width="243" height="8" font="font0" id="p1_t82" reading_order_no="82" segment_no="4" tag_type="text">trations of tumor necrosis factor- a are found in individuals</text>
<text top="273" left="306" width="243" height="8" font="font0" id="p1_t83" reading_order_no="83" segment_no="4" tag_type="text">with metabolic syndrome [51]. The positive correlations</text>
<text top="284" left="306" width="243" height="8" font="font0" id="p1_t84" reading_order_no="84" segment_no="4" tag_type="text">between plasma EL mass, obesity, and the other metabolic</text>
<text top="295" left="306" width="243" height="8" font="font0" id="p1_t85" reading_order_no="85" segment_no="4" tag_type="text">syndrome factors provide indirect evidence of a cytokine-</text>
<text top="306" left="306" width="243" height="8" font="font0" id="p1_t86" reading_order_no="86" segment_no="4" tag_type="text">mediated increase in endothelial EL protein secretion in the</text>
<text top="317" left="306" width="243" height="8" font="font0" id="p1_t87" reading_order_no="87" segment_no="4" tag_type="text">setting of obesity and metabolic syndrome. The signiﬁcant</text>
<text top="328" left="306" width="243" height="8" font="font0" id="p1_t88" reading_order_no="88" segment_no="4" tag_type="text">difference in EL mass between lean and obese participants</text>
<text top="339" left="306" width="163" height="8" font="font0" id="p1_t89" reading_order_no="89" segment_no="4" tag_type="text">also suggests that this may occur in vivo.</text>
<text top="351" left="315" width="234" height="8" font="font0" id="p1_t90" reading_order_no="90" segment_no="5" tag_type="text">An important ﬁnding of this study in healthy asymptomatic</text>
<text top="362" left="306" width="243" height="8" font="font0" id="p1_t91" reading_order_no="91" segment_no="5" tag_type="text">individuals is that EL mass concentrations are positively</text>
<text top="373" left="306" width="243" height="8" font="font0" id="p1_t92" reading_order_no="92" segment_no="5" tag_type="text">associated with CAC, a measure of subclinical atherosclerosis</text>
<text top="384" left="306" width="243" height="8" font="font0" id="p1_t93" reading_order_no="93" segment_no="5" tag_type="text">in humans, even after controlling for cardiovascular risk</text>
<text top="395" left="306" width="243" height="8" font="font0" id="p1_t94" reading_order_no="94" segment_no="5" tag_type="text">factors, plasma lipids, and vasoactive medications. The</text>
<text top="406" left="306" width="243" height="8" font="font0" id="p1_t95" reading_order_no="95" segment_no="5" tag_type="text">observation that EL tends to be a stronger predictor of</text>
<text top="418" left="306" width="243" height="8" font="font0" id="p1_t96" reading_order_no="96" segment_no="5" tag_type="text">CAC in women than in men could reﬂect the fact that HL</text>
<text top="429" left="306" width="243" height="8" font="font0" id="p1_t97" reading_order_no="97" segment_no="5" tag_type="text">activity is lower in women [52]. In the presence of less HL</text>
<text top="440" left="306" width="243" height="8" font="font0" id="p1_t98" reading_order_no="98" segment_no="5" tag_type="text">activity, EL might have a greater relative inﬂuence on HDL</text>
<text top="451" left="306" width="127" height="8" font="font0" id="p1_t99" reading_order_no="99" segment_no="5" tag_type="text">metabolism and atherosclerosis.</text>
<text top="462" left="315" width="234" height="8" font="font0" id="p1_t100" reading_order_no="100" segment_no="7" tag_type="text">Importantly, our analysis was based on measurement of EL</text>
<text top="473" left="306" width="243" height="8" font="font0" id="p1_t101" reading_order_no="101" segment_no="7" tag_type="text">mass, not EL activity. LPL and HL activity are generally</text>
<text top="484" left="306" width="243" height="8" font="font0" id="p1_t102" reading_order_no="102" segment_no="7" tag_type="text">measured in post-heparin plasma by assaying their triglycer-</text>
<text top="496" left="306" width="243" height="8" font="font0" id="p1_t103" reading_order_no="103" segment_no="7" tag_type="text">ide lipase activity. However, EL has much less triglyceride</text>
<text top="507" left="306" width="243" height="8" font="font0" id="p1_t104" reading_order_no="104" segment_no="7" tag_type="text">lipase activity compared with these enzymes. Therefore, EL</text>
<text top="518" left="306" width="243" height="8" font="font0" id="p1_t105" reading_order_no="105" segment_no="7" tag_type="text">activity in human plasma will need to be assessed based on its</text>
<text top="529" left="306" width="243" height="8" font="font0" id="p1_t106" reading_order_no="106" segment_no="7" tag_type="text">phospholipase activity and will require differentiation of EL-</text>
<text top="540" left="306" width="243" height="8" font="font0" id="p1_t107" reading_order_no="107" segment_no="7" tag_type="text">speciﬁc activity from other sources of phospholipase activity,</text>
<text top="551" left="306" width="243" height="8" font="font0" id="p1_t108" reading_order_no="108" segment_no="7" tag_type="text">such as HL. The development of a validated assay will allow</text>
<text top="562" left="306" width="243" height="8" font="font0" id="p1_t109" reading_order_no="109" segment_no="7" tag_type="text">determination of the association between EL mass and</text>
<text top="574" left="306" width="243" height="8" font="font0" id="p1_t110" reading_order_no="110" segment_no="7" tag_type="text">activity and EL activity with plasma lipids and atheroscle-</text>
<text top="585" left="306" width="20" height="8" font="font0" id="p1_t111" reading_order_no="111" segment_no="7" tag_type="text">rosis.</text>
<text top="596" left="315" width="234" height="8" font="font0" id="p1_t112" reading_order_no="112" segment_no="8" tag_type="text">In summary, EL mass is present in measurable amounts in</text>
<text top="607" left="306" width="243" height="8" font="font0" id="p1_t113" reading_order_no="113" segment_no="8" tag_type="text">pre-heparin plasma, and increases 3-fold after administration</text>
<text top="618" left="306" width="243" height="8" font="font0" id="p1_t114" reading_order_no="114" segment_no="8" tag_type="text">of heparin. EL concentrations are inversely associated with</text>
<text top="629" left="306" width="243" height="8" font="font0" id="p1_t115" reading_order_no="115" segment_no="8" tag_type="text">total HDL-C concentrations and positively associated with</text>
<text top="641" left="306" width="243" height="8" font="font0" id="p1_t116" reading_order_no="116" segment_no="8" tag_type="text">obesity, triglycerides, fasting glucose, and hypertension,</text>
<text top="652" left="306" width="243" height="8" font="font0" id="p1_t117" reading_order_no="117" segment_no="8" tag_type="text">factors composing the metabolic syndrome. Finally, plasma</text>
<text top="663" left="306" width="243" height="8" font="font0" id="p1_t118" reading_order_no="118" segment_no="8" tag_type="text">EL concentrations are associated with subclinical atheroscle-</text>
<text top="674" left="306" width="243" height="8" font="font0" id="p1_t119" reading_order_no="119" segment_no="8" tag_type="text">rosis independent of all established risk factors, including</text>
<text top="685" left="306" width="243" height="8" font="font0" id="p1_t120" reading_order_no="120" segment_no="8" tag_type="text">plasma lipids. These data support the concept that plasma EL</text>
<text top="696" left="306" width="243" height="8" font="font0" id="p1_t121" reading_order_no="121" segment_no="8" tag_type="text">concentrations may modulate metabolic dyslipidemia and</text>
<text top="707" left="306" width="243" height="8" font="font0" id="p1_t122" reading_order_no="122" segment_no="8" tag_type="text">atherosclerosis. Prospective studies will be needed to deter-</text>
<text top="719" left="306" width="140" height="8" font="font0" id="p1_t123" reading_order_no="123" segment_no="8" tag_type="text">mine if EL is, indeed, a risk factor.</text>
<text top="742" left="69" width="133" height="7" font="font3" id="p1_t124" reading_order_no="124" segment_no="10" tag_type="text">PLoS Medicine | www.plosmedicine.org</text>
<text top="742" left="411" width="138" height="7" font="font3" id="p1_t125" reading_order_no="126" segment_no="11" tag_type="text">February 2006 | Volume 3 | Issue 2 | e22</text>
<text top="742" left="289" width="16" height="7" font="font3" id="p1_t126" reading_order_no="125" segment_no="12" tag_type="text">0250</text>
<text top="26" left="454" width="95" height="7" font="font3" id="p1_t127" reading_order_no="0" segment_no="0" tag_type="title">EL and Metabolic Syndrome</text>
</page>
</pdf2xml>
